Corient Capital Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $594K | Hold |
15,947
| – | – | 0.04% | 302 |
|
|
2022
Q2 | $594K | Sell |
15,947
-4,362
| -21% | -$162K | 0.05% | 310 |
|
|
2022
Q1 | $899K | Buy |
20,309
+5,367
| +36% | +$238K | 0.06% | 261 |
|
|
2021
Q4 | $635K | Sell |
14,942
-2,661
| -15% | -$113K | 0.04% | 327 |
|
|
2021
Q3 | $764K | Buy |
17,603
+1,853
| +12% | +$80.4K | 0.06% | 265 |
|
|
2021
Q2 | $673K | Buy |
15,750
+2,745
| +21% | +$117K | 0.05% | 299 |
|
|
2021
Q1 | $502K | Buy |
13,005
+2,050
| +19% | +$79.1K | 0.04% | 318 |
|
|
2020
Q4 | $394K | Sell |
10,955
-23,501
| -68% | -$845K | 0.04% | 322 |
|
|
2020
Q3 | $1.32M | Buy |
34,456
+6,657
| +24% | +$254K | 0.15% | 132 |
|
|
2020
Q2 | $976K | Buy |
27,799
+17,499
| +170% | +$614K | 0.12% | 160 |
|
|
2020
Q1 | $336K | Sell |
10,300
-10,368
| -50% | -$338K | 0.05% | 275 |
|
|
2019
Q4 | $935K | Buy |
20,668
+6,542
| +46% | +$296K | 0.12% | 180 |
|
|
2019
Q3 | $575K | Buy |
14,126
+2,671
| +23% | +$109K | 0.08% | 238 |
|
|
2019
Q2 | $492K | Sell |
11,455
-576
| -5% | -$24.7K | 0.08% | 239 |
|
|
2019
Q1 | $462K | Buy |
12,031
+4,337
| +56% | +$167K | 0.08% | 233 |
|
|
2018
Q4 | $272K | Buy |
+7,694
| New | +$272K | 0.05% | 270 |
|